Unaudited Condensed Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2023	Mar. 31, 2023
Current assets:
Cash and cash equivalents	$ 20,161	$ 16,587
Restricted cash	449	140
Trade accounts receivable, net of allowance for doubtful accounts of $360 and $357 at September 30, 2023 and March 31, 2023, respectively	24,929	23,809
Unbilled accounts receivable	8,562	8,349
Inventories	10,781	10,841
Prepaid expenses and other current assets	4,079	3,128
Total current assets	68,961	62,854
Property and equipment, net	1,325	1,297
Right-of-use assets	7,509	8,345
Intangible assets, net	9,968	10,190
Goodwill	28,340	28,340
Other assets	502	768
Total assets	116,605	111,794
Current liabilities:
Trade accounts payable	14,942	12,943
Accrued payroll and related expenses	10,837	12,923
Accrued liabilities	5,654	5,453
Deferred revenue	7,322	6,720
Total current liabilities	38,755	38,039
Lease liabilities	6,560	7,641
Deferred income taxes	463	422
Unrecognized tax benefits	37	79
Other long-term liabilities	3,224	2,707
Total liabilities	49,039	48,888
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $1.00 par value: Authorized shares — 2,000 Issued and outstanding shares — none	0	0
Common stock, $0.10 par value: Authorized shares - 70,000 at June 30, 2023 and March 31, 2023 Issued and outstanding shares — 42,646 and 42,346, respectively, at June 30, 2023 and 42,416 and 42,416, respectively, at March 31, 2023	4,283	4,282
Treasury stock	(9)	(891)
Additional paid-in capital	192,037	190,082
Accumulated deficit	(128,745)	(130,567)
Total stockholders' equity	67,566	62,906
Total liabilities and stockholders' equity	$ 116,605	$ 111,794
Common stock, outstanding (in shares)	42,823,000	42,808,000